Effects of Obesity on Pharmacokinetics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 59
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, titled “Effects of Obesity on Pharmacokinetics”, explores the significance of obesity’s impact on drug disposition and metabolism. Obesity is a global health concern, and patients with obesity experience the same diseases as patients without obesity. We typically administer similar drugs and dosages to these patients, no matter their weight, and obesity-specific dosing has only seldomly been studied in controlled trials. Obesity may alter pharmacokinetic parameters, affecting drug efficacy and safety. The objective of this issue is to provide an in-depth understanding of how obesity influences drug absorption, distribution, metabolism, and excretion. By addressing this critical topic, and providing examples for pharmacokinetic studies in patiens with obesity, researchers and healthcare professionals can develop more effective pharmacotherapeutic strategies for patients with obesity, ultimately improving treatment outcomes and patient safety.
Prof. Dr. Stefan Engeli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- pharmacokinetics
- ADME
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
